Ginkgo Bioworks Holdings (DNA) Change in Receivables (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Change in Receivables of $242000.0 for Q1 2026, down 86.69% on a QoQ basis from $1.8 million in Q4 2025, and down 63.72% year-over-year from $667000.0 in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Change in Receivables (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Change in Receivables history runs 7 years deep, the most recent figure standing at $242000.0 for Q1 2026.
- Quarterly Change in Receivables fell 63.72% year-over-year to $242000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 176.05% YoY) and the FY2025 annual result came in at $1.5 million, down 68.83% from the prior year.
- Change in Receivables was $242000.0 for Q1 2026 at Ginkgo Bioworks Holdings, down from $1.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $6.8 million in Q1 2024 and bottomed at -$34.5 million in Q4 2022.
- A 5-year average of -$5.6 million and a median of -$506000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables tumbled 140.0% — and 2024, when it jumped 1187.07%.
- Ginkgo Bioworks Holdings' Change in Receivables stood at -$34.5 million in 2022, then rose by 16.24% to -$28.9 million in 2023, then surged by 95.24% to -$1.4 million in 2024, then soared by 232.12% to $1.8 million in 2025, then slumped by 86.69% to $242000.0 in 2026.
- Business Quant data shows DNA's Change in Receivables at $242000.0 in Q1 2026, $1.8 million in Q4 2025, and -$757000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | 242,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 242,000.00 |
| Mar 31, 2026 | 242,000.00 |
| Dec 31, 2025 | 1.82 Mn |
| Dec 31, 2025 | 1.82 Mn |
| Sep 30, 2025 | -757,000.00 |
| Sep 30, 2025 | -757,000.00 |
| Jun 30, 2025 | -255,000.00 |
| Jun 30, 2025 | -255,000.00 |
| Mar 31, 2025 | 667,000.00 |
| Mar 31, 2025 | 667,000.00 |
| Dec 31, 2024 | -1.38 Mn |
| Dec 31, 2024 | -1.38 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | -5.67 Mn |
| Jun 30, 2024 | -5.67 Mn |
| Mar 31, 2024 | 6.77 Mn |
| Mar 31, 2024 | 6.77 Mn |
| Dec 31, 2023 | -28.90 Mn |
| Dec 31, 2023 | -28.90 Mn |